title: Monoclonal antibodies, systemic lupus erythematosus, and pregnancy: insights from an open-label study.
authors.affiliation: Department of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
authors.forename: Vaneet K
authors.initials: VK
authors.lastname: Sandhu
authors.affiliation: Department of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Wallace
authors.affiliation: Department of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA. weisman@cshs.org.
authors.forename: Michael H
authors.initials: MH
authors.lastname: Weisman
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D011247:Pregnancy; D028761:Withholding Treatment
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; C511911:belimumab